Constructive Bio Collaborates with Ellison Institute's Generative Biology Institute on Synthetic Genomics for Health and Environment
10 October 2025

Constructive Bio entered a collaboration with the Ellison Institute of Technology's Generative Biology Institute (GBI) in Oxford, combining synthetic genome platforms to advance new medicines, disease-resistant cells, and sustainable materials.
Constructive Bio has entered a collaboration with the Ellison Institute of Technology and its Generative Biology Institute (GBI) in Oxford. The partnership brings together aligned missions to develop and apply synthetic genomics for human and planetary health.
Under the collaboration, GBI will use Constructive Bio’s synthetic genome platform to investigate new applications in programmable biology, including work related to cell engineering, materials, and future food systems. The partnership provides a framework for joint research and access to facilities and expertise across both organisations.
The collaboration was covered in The Times, which reported on the partnership and its potential to support the development of new medicines.
Read the article here